SCHEMBL7010502

SCHEMBL7010502

c1csc(C2CNCCO2)c1

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.47
DRD3 P35462 1/20 0.47
HTR1A P08908 1/20 0.44
HTR2A P28223 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetone SCHEMBL22660844 0.91 DRD2 (0.44) DRD2DRD3
SCHEMBL6630644 0.85 KDM4E (0.38) DRD2DRD3
SCHEMBL30100984 0.85 KDM4E (0.36) DRD2DRD3HTR1AHTR2A
SCHEMBL30100996 0.83 DRD2 (0.45) DRD2DRD3HTR1AHTR2A
SCHEMBL30101002 0.79 DRD2 (0.36) DRD2DRD3HTR1AHTR2A
SCHEMBL19690771 0.79
SCHEMBL27659433 0.76
SCHEMBL28049062 0.75 DRD2 (0.39) DRD2DRD3HTR1A
SCHEMBL19354579 0.74
SCHEMBL1522730 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115433205-A Polycyclic derivative receptor agonist, preparation method and application thereof 上海翰森生物医药科技有限公司 2022-12-06 CN disclosed
CN-108997372-B Compound for positron imaging, intermediate thereof, preparation method and imaging agent 华中科技大学同济医学院附属协和医院 2020-07-28 CN disclosed
CN-108997372-A Positron imaging compound, wherein mesosome, preparation method and imaging agent 华中科技大学同济医学院附属协和医院 2018-12-14 CN disclosed
CN-104470924-B Imidazopyrazines derivant as TNF active regulator UCB生物制药私人有限公司 2016-11-09 CN disclosed
CN-102970868-A Treatment of cancers having K-RAS mutations CURIS INC 2013-03-13 CN disclosed
CN-1553900-A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents ��ʱ��ʩ����ҩ��˾ 2004-12-08 CN disclosed
CN-1419545-A 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors WYETH CORP (US) 2003-05-21 CN disclosed
EP-1268431-A1 3-CYANOQUINOLINES,3-CYANO-1,6-NAPHTHYRIDINES, AND 3-CYANO-1,7-NAPHTHYRIDINES AS PROTEIN KINASE INHIBITORS Wyeth (US) 2003-01-02 EP disclosed
WO-2001072711-A1 3-CYANOQUINOLINES,3-CYANO-1,6-NAPHTHYRIDINES, AND 3-CYANO-1,7-NAPHTHYRIDINES AS PROTEIN KINASE INHIBITORS WYETH (US) 2001-10-04 WO disclosed
US-5852006-A N-aminoalkyl-substituted nitrogen-containing six membered heterocyclic compounds NIPPON CHEMIPHAR CO., LTD. (JP) 1998-12-22 US disclosed
US-5773437-A UROGENITAL DISORDERS SUCH AS DYSURIA NIPPON CHEMIPHAR CO., LTD. (JP) 1998-06-30 US disclosed
US-5574030-A INHIBITING URINARY CONTRACTION, HETEROCYCLIC DIAMINES NIPPON CHEMIPHAR CO., LTD. (JP) 1996-11-12 US disclosed